Journal of endocrinological investigation
-
J. Endocrinol. Invest. · Oct 2020
Observational StudyImmune checkpoint inhibitor-associated pituitary adverse events: an observational, retrospective, disproportionality study.
The aim of this study was to identify and characterize immune checkpoint inhibitors (ICIs)-associated pituitary adverse events (AEs). ⋯ ICI-associated pituitary adverse events have significantly increased, and their clinical characteristics should be kept in mind by oncologists and endocrinologists who manage patients treated by immunotherapy.